207 related articles for article (PubMed ID: 32269533)
1. Comorbidity of Narcolepsy and Psychotic Disorders: A Nationwide Population-Based Study in Taiwan.
Yeh JY; Shyu YC; Lee SY; Yuan SS; Yang CJ; Yang KC; Lee TL; Sun CC; Wang LJ
Front Psychiatry; 2020; 11():205. PubMed ID: 32269533
[TBL] [Abstract][Full Text] [Related]
2. Comorbidity of narcolepsy and depressive disorders: a nationwide population-based study in Taiwan.
Lee MJ; Lee SY; Yuan SS; Yang CJ; Yang KC; Lee TL; Sun CC; Shyu YC; Wang LJ
Sleep Med; 2017 Nov; 39():95-100. PubMed ID: 29157595
[TBL] [Abstract][Full Text] [Related]
3. Initiation and Persistence of Pharmacotherapy for Youths with Attention Deficit Hyperactivity Disorder in Taiwan.
Wang LJ; Yang KC; Lee SY; Yang CJ; Huang TS; Lee TL; Yuan SS; Shyu YC
PLoS One; 2016; 11(8):e0161061. PubMed ID: 27518196
[TBL] [Abstract][Full Text] [Related]
4. Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan.
Shyu YC; Yuan SS; Lee SY; Yang CJ; Yang KC; Lee TL; Wang LJ
Schizophr Res; 2015 Oct; 168(1-2):161-7. PubMed ID: 26363968
[TBL] [Abstract][Full Text] [Related]
5. Seasonal Patterns of Medications for Treating Attention-Deficit/Hyperactivity Disorder: Comparison of Methylphenidate and Atomoxetine.
Shyu YC; Lee SY; Yuan SS; Yang CJ; Yang KC; Lee TL; Wang LJ
Clin Ther; 2016 Mar; 38(3):595-602. PubMed ID: 26874787
[TBL] [Abstract][Full Text] [Related]
6. Sex and age differences in the association between anxiety disorders and narcolepsy: A nationwide population-based case control study.
Chen TY; Huang CH; Chung CH; Mao WC; Yeh CB; Yang CCH; Kuo TBJ; Yang SS; Chien WC; Tzeng NS
J Affect Disord; 2020 Mar; 264():130-137. PubMed ID: 32056742
[TBL] [Abstract][Full Text] [Related]
7. Impact of negative media publicity on attention-deficit/hyperactivity disorder medication in Taiwan.
Wang LJ; Lee SY; Yuan SS; Yang CJ; Yang KC; Lee TL; Shyu YC
Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):45-53. PubMed ID: 26549311
[TBL] [Abstract][Full Text] [Related]
8. Attention-deficit hyperactivity disorder, its treatment with medication and the probability of developing a depressive disorder: A nationwide population-based study in Taiwan.
Lee MJ; Yang KC; Shyu YC; Yuan SS; Yang CJ; Lee SY; Lee TL; Wang LJ
J Affect Disord; 2016 Jan; 189():110-7. PubMed ID: 26433758
[TBL] [Abstract][Full Text] [Related]
9. Attention-Deficit/Hyperactivity Disorder, Its Pharmacotherapy, and Adrenal Gland Dysfunction: A Nationwide Population-Based Study in Taiwan.
Peng PH; Tsai MY; Lee SY; Liao PC; Shyu YC; Wang LJ
Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32466107
[TBL] [Abstract][Full Text] [Related]
10. Trend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: a nationwide survey in Taiwan.
Cheng YS; Shyu YC; Lee SY; Yuan SS; Yang CJ; Yang KC; Lee TL; Wang LJ
Neuropsychiatr Dis Treat; 2017; 13():643-651. PubMed ID: 28280346
[TBL] [Abstract][Full Text] [Related]
11. Attention-deficit hyperactivity disorder, its pharmacotherapy, and the risk of developing bipolar disorder: A nationwide population-based study in Taiwan.
Wang LJ; Shyu YC; Yuan SS; Yang CJ; Yang KC; Lee TL; Lee SY
J Psychiatr Res; 2016 Jan; 72():6-14. PubMed ID: 26519764
[TBL] [Abstract][Full Text] [Related]
12. Risk of Burn Injury in Patients With Narcolepsy: A Nationwide Population-Based Cohort Study.
Chang ET; Lin CL; Chen SF; Shen YC
J Burn Care Res; 2020 May; 41(3):663-667. PubMed ID: 31927592
[TBL] [Abstract][Full Text] [Related]
13. Narcolepsy and psychosis: A systematic review.
Hanin C; Arnulf I; Maranci JB; Lecendreux M; Levinson DF; Cohen D; Laurent-Levinson C
Acta Psychiatr Scand; 2021 Jul; 144(1):28-41. PubMed ID: 33779983
[TBL] [Abstract][Full Text] [Related]
14. The Association Between Asthma and Narcolepsy: A Nationwide Case-Control Study in Taiwan.
Chen TY; Su VY; Lee CH; Chung CH; Tsai CK; Peng CK; Lai HC; Chien WC; Tzeng NS
Nat Sci Sleep; 2021; 13():1631-1640. PubMed ID: 34584477
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric Correlates of Narcolepsy.
BaHammam AS; Alnakshabandi K; Pandi-Perumal SR
Curr Psychiatry Rep; 2020 Jun; 22(8):36. PubMed ID: 32514698
[TBL] [Abstract][Full Text] [Related]
16. The Risk of Hospitalization for Motor Vehicle Accident Injury in Narcolepsy and the Benefits of Stimulant Use: A Nationwide Cohort Study in Taiwan.
Tzeng NS; Hsing SC; Chung CH; Chang HA; Kao YC; Mao WC; Yang CCH; Kuo TBJ; Chen TY; Chien WC
J Clin Sleep Med; 2019 Jun; 15(6):881-889. PubMed ID: 31138389
[TBL] [Abstract][Full Text] [Related]
17. A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder.
Steele M; Weiss M; Swanson J; Wang J; Prinzo RS; Binder CE
Can J Clin Pharmacol; 2006; 13(1):e50-62. PubMed ID: 16456216
[TBL] [Abstract][Full Text] [Related]
18. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
19. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
20. Switching from Methylphenidate-Immediate Release (MPH-IR) to Methylphenidate-OROS (OROS-MPH): A Multi-center, Open-label Study in Korea.
Kim BN; Kim YN; Cheong US; Kim JW; Hwang JW; Shin MS; Cho SC;
Clin Psychopharmacol Neurosci; 2011 Apr; 9(1):29-35. PubMed ID: 23430964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
